ArticleChemical biology & drug design2026

In Silico Drug Repositioning Identifies SYK Kinase Inhibitors as Potential Neuroprotective Agents for Ataxia-Telangiectasia.

Alessia Romano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.